GlassScriptPhysician profile
Craig J Peterson
NPI 1912963307
$259.07
in general payments reported to CMS, 2019-2025
5 companies · $190 in 2025
The $190 reported for 2025 was more than what 79% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $21.18 · 2024: $47.98 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $134.09 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $36.33 | 2023-2024 | Onivyde, Somatuline Depot |
| Haemonetics Corporation | $36.29 | 2024-2025 | Teg6s Hemostasis System |
| Pharmacosmos Therapeutics INC. | $34.74 | 2025 | Monoferric |
| Siemens Medical Solutions USA, INC. | $17.62 | 2024 | Atellica Ch 930 Analyzer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.